This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Analysts' Actions: AIG, DOW, EZPW, FOSL

Stocks in this article: AIGDOWFOSLEZPWUA

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Aetna (AET) was downgraded from Neutral to Sell at Goldman Sachs. Commercial margins could continue to fall, Goldman said. $45 price target.

AIG (AIG) was upgraded to Buy at Goldman Sachs. Chart is is showing progress, and the company has multiple potential catalysts, Goldman said. $40 price target.

CF Industries (CF) was downgraded at Dahlman Rose. Higher corn supplies could weigh on prices, Dahlman Rose said. $155 price target.

Dish (DISH) was downgraded to Hold at TheStreet Ratings.

Dow Chemical (DOW) was upgraded at Morgan Stanley from Equal-Weight to Overweight. $38 price target. Company should benefit from lower ethane prices, Morgan Stanley said.

EZCorp (EZPW) was upgraded at Sterne Agee from Underperform to Neutral. Valuation call, based on a $24 price target, Sterne Agee said.

Fossil (FOSL) was upgraded at Benchmark from Hold to Buy. $100 price target. Estimates also cut, given lower expected sales in Europe, Benchmark said.

Fossil was downgraded at JP Morgan from Overweight to Neutral. Company's growth story is in transition, JP Morgan said. $88 price target.

Generac Holdings (GNRC) was downgraded at Goldman Sachs to Neutral from Buy. $30 price target. Risk reward around consensus estimates is now balanced, Goldman said.

Global Partners (GLP) was downgraded to Hold at TheStreet Ratings.

Herbalife (NOK) was downgraded at Caris & Co. from Buy to Average. $39 price target. Expect David Einhorn to weigh on sentiment, Caris said.

Hershey (HSY) was upgraded at Argus from Hold to Buy. $78 price target. Company is realizing higher sales growth, Argus said.

Humana (HUM) was downgraded at Goldman Sachs from Buy to Neutral. Valuation call, based on a $90 price target, Goldman said.

Immunomedics (IMMU) was downgraded to Hold at TheStreet Ratings.

Jive Software (JIVE) was initiated with a Hold rating at Needham. Valuation call, Needham said.

Janus Capital (JNS) was upgraded at Bank of America/Merrill Lynch from Underperform to Neutral. Valuation call, based on an $8.50 price target, Bank of America/Merrill Lynch said.

Magellan Health Services (MGLN) was upgraded at Bank of America/Merrill to Buy from Underperform. $52 price target. Big contract extension derisks outlook, BofA/Merrill said.

Phillips 66 (PSX) was initiated with an Outperform rating at Credit Suisse. $42 price target. Company can deliver above-average growth, Credit Suisse said.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,828.24 +0.49 0.00%
S&P 500 2,067.56 -5.27 -0.25%
NASDAQ 4,791.63 +4.3130 0.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs